# Low Molecular Weight Heparin for Hemodialysis Anticoagulation

> **NCT01356615** · NA · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 27 (actual)

## Conditions studied

- End Stage Renal Failure on Dialysis

## Interventions

- **DRUG:** low molecular weight heparin (enoxaparin sodium)
- **DRUG:** standard unfractionated heparin

## Key facts

- **NCT ID:** NCT01356615
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356615, "Low Molecular Weight Heparin for Hemodialysis Anticoagulation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01356615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*